Related Experiment Videos
Hypercalcaemia in elderly hospital in-patients: value of discriminant analysis in differential diagnosis
Insights
Pathological hypercalcaemia affects 1.33% of geriatric patients, often linked to bone metastases or hyperparathyroidism. Discriminant analysis may aid differential diagnosis in elderly patients with normal renal function.
Area of Science:
- Geriatric Medicine
- Clinical Biochemistry
- Oncology
Background:
- Hypercalcaemia is a common electrolyte disturbance in hospitalized patients.
- Routine screening in geriatric admissions identified a significant prevalence of pathological hypercalcaemia.
- Causes of hypercalcaemia in the elderly are diverse and can be challenging to diagnose.
Purpose of the Study:
- To determine the prevalence and causes of pathological hypercalcaemia in a geriatric inpatient population.
- To evaluate the utility of discriminant analysis in differentiating causes of hypercalcaemia in elderly patients with normal renal function.
Main Methods:
- Prospective screening of plasma calcium levels in geriatric admissions.
- Analysis of identified causes of pathological hypercalcaemia.
- Application of discriminant analysis to biochemical data for differential diagnosis in patients with normal renal function.
Main Results:
- Pathological hypercalcaemia was detected in 1.33% of screened geriatric patients.
- Leading causes included bone metastases (29%), hyperparathyroidism (21%), and bronchial carcinoma (18.5%).
- Discriminant analysis demonstrated biochemical distinguishability among major diagnostic groups in patients with normal renal function.
Conclusions:
- Hypercalcaemia is a notable finding in geriatric admissions, with diverse underlying etiologies.
- Discriminant analysis shows promise for aiding the differential diagnosis of hypercalcaemia in elderly patients with preserved renal function.
- Further prospective validation is required to confirm the clinical utility of this diagnostic approach.
Abstract:
Plasma calcium was measured routinely as a part of profile screening of patients admitted to a geriatric department. Pathological hypercalcaemia was found in 1.33% of those screened, the cause being bone metastases (29%), hyperparathyroidism (21%), bronchial carcinoma without bone metastasis (18.5%), lymphosarcoma without bone metastasis (8%) and multiple myeloma (2.5%). There remained a further group of patients with hypercalcaemia and renal failure (21%) in whom diagnosis was often obscure. Where renal function was normal, discriminant analysis showed that the four main diagnostic groups were biochemically distinguishable. Discriminant analysis thus seems likely to be of practical value in the differential diagnosis of hypercalcaemia in elderly patients with normal renal function, but requires prospective validation.